EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 9th, 2017 • uniQure N.V. • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2017 Company Industry JurisdictionTHIS Exclusive License Agreement (“Agreement”), effective as of 07 July 2008 (“Effective Date”), is entered into by and between St. Jude Children’s Research Hospital, Inc., a Tennessee not-for-profit corporation located at 262 Danny Thomas Place, Memphis, Tennessee 38105 (“ST. JUDE”) and Amsterdam Molecular Therapeutics B.V., a closed limited liability company organized and existing under the laws of the Netherlands, with registered offices at Meibergdreef 61, 1105 BA Amsterdam, the Netherlands, (each a “Party” and together the “Parties”).